NEW YORK, Nov. 22, 2019 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) between September 11, 2019 and November 14, 2019, inclusive (the “Class Period”). The lawsuit filed in the United States District Court for the District of New Jersey alleges violations of the Securities Exchange Act of 1934.
— Third quarter 2019 revenue of $14.1 million, an increase of 22% over last year
TORONTO, le 21 nov. 2019 /CNW/ – Le récent retour du gouvernement Ford à sa décision désastreuse de privatiser la vente de cannabis ne fera qu’empirer une situation déjà mauvaise, affirme le président du SEFPO, Warren (Smokey) Thomas.
TORONTO and GLIL YAM, Israel, Nov. 21, 2019 /CNW/ – IM Cannabis Corp. (the “Company” or “IMC”) (CSE: IMCC), one of the world’s pioneering medical cannabis companies with operations across Europe, is pleased to announce that 9,730,258 warrants of the Company (the “Warrants”) have begun trading on the Canadian Securities Exchange (the “CSE”) under the trading symbol “IMCC.WT”. Each Warrant, entitles the holder thereof to purchase one common share in the capital of the Company at an exercise price of $1.30 until October 11, 2021.
VANCOUVER, British Columbia , Nov. 21, 2019 /PRNewswire/ — Pasha Brands Ltd. (“Pasha or the Company”) (CSE: CRFT) (OTC: CRFTF) (FSE: ZZD), Canada’s largest craft cannabis brands organization, has responded to both the contraction in the capital markets and Health Canada‘s slow roll out of the micro cultivation licensing program by focussing more of its resources on getting its two pre-roll brands, Grizzlers and Roll Model, onto the shelves for the first quarter of 2020.
OTTAWA, Nov. 21, 2019 /CNW/ – According to Statistics Canada, there are 811,000 Canadians taking recreational or illegal cannabis products for their health without a doctor note/prescription. These are not products that have been approved by Health Canada as over-the-counter medicines (OTCs) or natural health products (NHPs). Until Health Canada changes the law that prevents the manufactures of OTCs and NHPs from seeking their approval, they never will be.
OTTAWA, le 21 nov. 2019 /CNW/ – Selon Statistique Canada, quelque 811 000 Canadiens utilisent des produits de cannabis récréatif ou illicite à des fins de santé et ce, sans avis ni ordonnance du médecin. Ces produits ne sont pas approuvés par Santé Canada à titre de médicaments en vente libre ou de produits de santé naturelle. Tant que Santé Canada n’aura pas modifié la loi qui empêche les fabricants de médicaments en vente libre et de produits de santé naturelle de demander leur approbation, ils ne le seront pas.
AcesoHemp topical range will be on shelves in all 120 Huck’s Market supermarket and convenience stores by the end of November
Invibe® MD is Better with CBD
TORONTO, Nov. 21, 2019 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that Company Director and 55(th) President of Mexico, Vicente Fox, will present a keynote address at the Bryan, Garnier & Co Cannabis Conference, taking place on Thursday, November 28, 2019 in London, UK.